US Pre-Market SEC Filings Roundup — February 09, 2026

10-02-2026

DuPont de Nemours, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001666700-26-000007), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, likely an earnings release. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are mentioned in the provided filing details.

10-02-2026

WESCO INTERNATIONAL INC filed an 8-K on February 10, 2026 (AccNo: 0000929008-26-000005), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, internal/external status, timing, or any compensatory arrangements are NOT_DISCLOSED. No quantitative data, performance metrics, scheduled events, or governance impacts are mentioned.

10-02-2026

Axalta Coating Systems Ltd. filed an 8-K on February 10, 2026, reporting results of operations and financial condition under Item 2.02. The filing includes financial statements and exhibits under Item 9.01. No specific financial metrics, quantitative data, period-over-period comparisons, guidance, or other details were provided in the filing summary.

10-02-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary.

10-02-2026

REGENXBIO Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001193125-26-043342), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific core events, transactions, financial metrics, or quantitative data are disclosed in the provided filing summary. This is a multi-item filing with no details on timing relative to events or materiality.

10-02-2026

Ares Commercial Real Estate Corp filed a Form 8-K on February 10, 2026 (AccNo: 0001628280-26-006634), disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing pertains to financial results, likely quarterly or annual earnings. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed in the provided filing information.

10-02-2026

Destiny Media Technologies Inc. filed an 8-K on 2026-02-10 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits are included. No specific details on positions affected, individuals involved, reasons for change, or compensation amounts are disclosed.

10-02-2026

Republic Airways Holdings Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001193125-26-043297), reporting under Item 3.02 for unregistered sales of equity securities and Item 8.01 for other events. This is a multi-item filing with no quantitative details such as transaction values, share counts, financial impacts, or period-over-period comparisons disclosed. No positive or negative metrics, guidance changes, or scheduled events were mentioned.

10-02-2026

FG Nexus Inc. filed an 8-K on February 10, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure with no specific transaction details, financial metrics, or quantitative data provided in the filing metadata. No positive or negative performance indicators are disclosed.

10-02-2026

News Corp filed an 8-K on February 10, 2026 (AccNo: 0001564708-26-000031, Size: 399 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of any financial statements/exhibits are disclosed. This is a multi-item filing with no quantitative metrics, transaction details, or directional information provided.

10-02-2026

Virtuix Holdings Inc. filed an 8-K on February 10, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement's parties, terms, value, strategic importance, or financial impacts are disclosed. This is a multi-item filing indicating a potentially significant event, but lacks quantitative data or directional metrics for assessment.

10-02-2026

Calidi Biotherapeutics, Inc. filed an 8-K on February 10, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details, financial metrics, transactions, or directional information are disclosed in the provided filing summary. This appears to be a voluntary informational filing with attached exhibits, such as a press release or presentation.

10-02-2026

ScanTech AI Systems Inc. filed an 8-K on 2026-02-10 reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, along with transfer of listing, which is a material negative event. The filing also includes Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No quantitative financial metrics, dollar values, or period-over-period comparisons are disclosed.

10-02-2026

Webstar Technology Group Inc. filed an 8-K on February 10, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement's nature, parties, dollar value, financial impacts, or strategic rationale are disclosed in the provided filing summary. This represents a multi-item mandatory disclosure of a material event.

10-02-2026

urban-gro, Inc. filed a Form 8-K on February 10, 2026, disclosing under Item 1.01 its entry into a Material Definitive Agreement. Item 9.01 lists Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are provided in the filing summary.

10-02-2026

Silvaco Group, Inc. filed an 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the financial statements and exhibits are disclosed in the filing summary. No quantitative metrics, transactions, or scheduled events are mentioned.

10-02-2026

Consensus Cloud Solutions, Inc. filed an 8-K on February 10, 2026, disclosing results of operations and financial condition under Item 2.02 and an officer change or appointment under Item 5.02, with financial statements and exhibits under Item 9.01. Specific details on the affected position, whether it is an appointment or resignation, reasons for the change, and any financial metrics are NOT_DISCLOSED. No quantitative data, named executives, or scheduled events are provided in the filing summary.

10-02-2026

ZipRecruiter, Inc. filed an 8-K on February 10, 2026 (AccNo: 0001617553-26-000004, Size: 204 KB), disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, appointment/resignation status, reasons, individuals involved, or any quantitative metrics are disclosed.

10-02-2026

Lottery.com Inc. filed an 8-K on February 10, 2026, disclosing under Item 5.07 the submission of matters to a vote of security holders, likely related to a shareholder meeting, and under Item 9.01 financial statements and exhibits. No specific vote outcomes, financial metrics, or other quantitative details are provided in the filing summary.

10-02-2026

M2i Global, Inc. filed a Form 8-K on February 10, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely providing voluntary disclosure of material information with attached exhibits, such as a press release or presentation. No specific financial metrics, transactions, events, or quantitative data are disclosed in the filing summary.

• ·Accession Number: 0001493152-26-005830
• ·Filing size: 9 MB

10-02-2026

Duke Energy Corporation filed a Form 8-K on February 10, 2026, disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific quantitative financial metrics, period-over-period comparisons, guidance, or other performance details are provided in the filing description.

10-02-2026

Southern Missouri Bancorp, Inc. filed an 8-K on February 10, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transactions, guidance, or operational details are disclosed in the filing summary provided. This appears to be a voluntary informational filing with attached exhibits, but content details are NOT_DISCLOSED.

10-02-2026

Synchrony Financial filed a Form 8-K on February 10, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item voluntary disclosure intended to release material nonpublic information, with exhibits likely attached (filing size 292 KB). No specific financial metrics, transactions, positive or negative changes, or other quantitative details are disclosed in the provided filing summary.

10-02-2026

Oscar Health, Inc. filed a Form 8-K on February 10, 2026, disclosing multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 2.02 (Results of Operations and Financial Condition), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing covering a material agreement, financial results, and new financial obligations, but specific details, metrics, or impacts are NOT_DISCLOSED. No quantitative financial data, period-over-period comparisons, or directional performance indicators (positive, negative, or flat) are provided.

10-02-2026

10-02-2026

HASBRO, INC. filed an 8-K on February 10, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or period-over-period metrics are disclosed in the provided filing information. This is an informational earnings-related disclosure without detailed quantitative data.

10-02-2026

Aramark filed an 8-K on February 10, 2026 (AccNo: 0001584509-26-000037, Size: 919 KB), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, or other quantitative financial metrics are disclosed in the provided filing information. No positive or negative performance indicators, guidance, or comparisons are mentioned.

10-02-2026

CVS Health Corp filed an 8-K on February 10, 2026 (AccNo: 0000064803-26-000009), reporting under Item 2.02 Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantitative metrics available for analysis.

10-02-2026

Zimmer Biomet Holdings, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001193125-26-043620), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item filing related to financial results, but specific revenue, earnings, guidance, or period-over-period metrics are NOT_DISCLOSED in the provided information. No positive, negative, or flat performance indicators are available.

10-02-2026

Quest Diagnostics Inc. filed a Form 8-K on February 10, 2026, under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing details. This is a multi-item filing typical for earnings releases, but lacks detailed performance data for analysis.

10-02-2026

LiveWire Group, Inc. filed an 8-K on February 10, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other financial metrics are disclosed in the provided filing information. No positive or negative performance indicators are mentioned.

10-02-2026

Harley-Davidson, Inc. filed an 8-K on February 10, 2026, disclosing results of operations and financial condition under Item 2.02 and officer changes including departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements under Item 5.02. Item 9.01 references financial statements and exhibits. Specific details on the officer position, appointment or resignation reason, financial metrics, or performance comparisons are NOT_DISCLOSED.

10-02-2026

Blackbaud Inc filed a Form 8-K on February 10, 2026, under Item 2.02 disclosing results of operations and financial condition. Item 9.01 includes financial statements and exhibits. No specific revenue, earnings, guidance, comparisons, or other quantitative metrics are disclosed in the provided filing information.

10-02-2026

European Wax Center, Inc. filed a Form 8-K on 2026-02-10 reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the nature of the agreement, events, or exhibits provided in the summary. No financial metrics, positive or negative changes, or quantitative impacts are disclosed.

10-02-2026

Incyte Corp filed an 8-K on February 10, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), indicating a standard disclosure of financial results. No specific revenue, earnings, margins, guidance, or other quantitative metrics are mentioned in the provided filing details. This multi-item filing appears informational without detailed performance data.

10-02-2026

Trimble Inc. filed an 8-K on February 10, 2026 (AccNo: 0000864749-26-000006), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits.

• ·Filing size: 663 KB
• ·Event Type: Financial Results
• ·Sector: NOT_DISCLOSED

10-02-2026

Xylem Inc. filed an 8-K on February 10, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons were disclosed in the provided filing details. This appears to be a standard earnings announcement filing with no quantified metrics available.

10-02-2026

Entegris Inc filed an 8-K on February 10, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons were disclosed in the provided filing details. This represents a standard voluntary disclosure of financial results without quantified metrics.

10-02-2026

Target Corp filed an 8-K on February 10, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individual names, appointment or resignation status, reasons for the change, or timing are provided in the filing summary. No quantitative metrics, financial impacts, or further governance implications are disclosed.

10-02-2026

Bread Financial Holdings, Inc. filed an 8-K on February 10, 2026 (AccNo: 0001101215-26-000010, size: 361 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details regarding the Regulation FD disclosure, financial statements, exhibits, transactions, metrics, or events are provided in the filing summary. Content of the disclosure is NOT_DISCLOSED.

10-02-2026

Masco Corp /DE/ filed an 8-K on February 10, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are disclosed in the filing description. This is an informational earnings-related disclosure without detailed performance data.

10-02-2026

ProPetro Holding Corp. filed an 8-K on 2026-02-10 reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, financial metrics, positive or negative impacts, or period-over-period comparisons are provided in the filing summary.

• ·Accession Number: 0001104659-26-012332
• ·File Size: 245 KB
• ·Sector: NOT_DISCLOSED

10-02-2026

Marriott International Inc. filed an 8-K on February 10, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance indicators, segment details, or outlook revisions are mentioned.

10-02-2026

Forgent Power Solutions, Inc. filed a multi-item Form 8-K on February 10, 2026, reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), and material modifications to rights of security holders (Item 3.03), alongside changes in directors or officers and compensatory arrangements (Item 5.02) and amendments to articles of incorporation or bylaws (Item 5.03). While the material agreement may represent strategic advancement, the equity sales and rights modifications raise concerns over potential dilution and altered shareholder protections. No quantitative transaction values, financial impacts, or performance metrics are disclosed.

10-02-2026

Coca-Cola Co filed an 8-K on February 10, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard voluntary earnings disclosure with attached exhibits.

10-02-2026

Fiserv Inc filed an 8-K on February 10, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are mentioned in the filing details provided. All quantitative data such as transaction values, percentages, or period-over-period comparisons are NOT_DISCLOSED.

10-02-2026

Datadog, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001628280-26-006645, Size: 589 KB), under Item 2.02 to disclose its results of operations and financial condition as part of a financial results event. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are mentioned in the provided filing information. Sector details are not specified.

10-02-2026

Vestis Corp filed a Form 8-K on February 10, 2026 (AccNo: 0001628280-26-006644, Size: 4 MB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This discloses financial results but no specific revenue, earnings, guidance, or period-over-period metrics are mentioned in the provided filing details. No positive or negative performance indicators are available.

10-02-2026

S&P Global Inc. filed a Form 8-K on 2026-02-10 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), indicating a financial results announcement likely related to quarterly or annual earnings. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing metadata. This is a standard multi-item 8-K for earnings release with attached exhibits.

10-02-2026

Phio Pharmaceuticals Corp. filed an 8-K on February 10, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events, financial statements, or exhibits are disclosed. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.

10-02-2026

The company filed a Form 8-K on February 10, 2026 (AccNo: 0001104659-26-012343), disclosing multiple events including entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No quantitative data, transaction details, financial impacts, or specific descriptions of the events are provided in the filing summary. This multi-item filing indicates significant developments but lacks specifics for impact assessment.

10-02-2026

Soluna Holdings, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001493152-26-005888, size: 277 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the disclosed information, transactions, financial metrics, or events provided. No quantitative data or performance metrics are mentioned.

10-02-2026

Harvard Bioscience Inc filed an 8-K on February 10, 2026 (AccNo: 0001171843-26-000721), disclosing results of operations and financial condition under Item 2.02 along with financial statements and exhibits under Item 9.01. No revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are explicitly stated in the filing description. This is a standard multi-item earnings-related disclosure with no directional performance indicators provided.

10-02-2026

Saia Inc filed an 8-K on 2026-02-10 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the filing summary provided. This appears to be a standard earnings-related disclosure without quantified metrics available.

10-02-2026

XPLR Infrastructure, LP filed an 8-K on 2026-02-10 reporting under Item 1.01 entry into a material definitive agreement, Item 2.02 results of operations and financial condition, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with no specific transaction details, dollar values, financial metrics, period-over-period comparisons, or performance directions (positive/negative/flat) disclosed. Critical details such as agreement terms, financial impacts, and quantitative data are NOT_DISCLOSED.

10-02-2026

Williams Companies, Inc. filed an 8-K on 2026-02-10 disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. This is a multi-item filing reporting financial results, but specific revenue, earnings, margins, comparisons, or guidance metrics are NOT_DISCLOSED. No positive or negative performance indicators, segment details, or balance sheet changes are provided in the filing description.

• ·AccNo: 0000107263-26-000003
• ·File size: 1 MB
• ·Sector: not specified

10-02-2026

Invesco Ltd. filed an 8-K on February 10, 2026, under Item 7.01 for Regulation FD Disclosure, indicating a voluntary release of material nonpublic information, and Item 9.01 for Financial Statements and Exhibits. This multi-item filing complies with Reg FD safe harbor but provides no specific details on the disclosed information, transactions, financial metrics, or impacts. No quantitative data, positive or negative metrics, or period-over-period comparisons are mentioned.

10-02-2026

Nektar Therapeutics filed an 8-K on February 10, 2026, under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific core events, transactions, financial metrics, or quantitative details are disclosed in the provided filing summary. This is a multi-item filing with no mentioned positive or negative performance indicators.

10-02-2026

Ecolab Inc. filed an 8-K on February 10, 2026, disclosing results of operations and financial condition under Item 2.02 alongside costs associated with exit or disposal activities under Item 2.05, indicating potential restructuring expenses. Financial statements and exhibits are provided under Item 9.01. No specific revenue, earnings, costs, guidance, or period-over-period metrics are disclosed.

10-02-2026

Genprex, Inc. filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed in the provided filing summary. No quantitative metrics, positive or negative changes, or material transactions are mentioned.

10-02-2026

GCM Grosvenor Inc. filed an 8-K on February 10, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing announcing financial results, but no specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided summary. No quantitative metrics, positive or negative changes, or flat performance indicators are mentioned.

10-02-2026

CTS Corp filed an 8-K on February 10, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits (filing size 11 MB). This multi-item filing provides material non-public information via attached exhibits to comply with Regulation FD. No specific financial metrics, transactions, or performance data are disclosed in the provided filing information.

10-02-2026

Fifth Third Bancorp filed an 8-K on February 10, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing providing voluntary disclosure of material non-public information with attached exhibits. No quantitative financial metrics, transaction details, or performance comparisons are disclosed in the filing summary.

10-02-2026

Galecto, Inc. filed an 8-K on February 10, 2026 (AccNo: 0001193125-26-043741), disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements), amendments to articles of incorporation or bylaws or fiscal year change under Item 5.03, other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details on positions affected, reasons for changes, board impacts, or quantitative data are NOT_DISCLOSED. No positive or negative metrics reported.

• ·Filing size: 290 KB

10-02-2026

Oxbridge Re Holdings Ltd filed a Form 8-K on February 10, 2026, under Item 7.01 Regulation FD Disclosure, indicating a voluntary release of material non-public information, and Item 9.01 Financial Statements and Exhibits, which attaches supporting documents. No specific details, financial metrics, transactions, or quantitative data are disclosed in the provided filing summary. This appears to be an informational filing without directional financial impact.

10-02-2026

Shift4 Payments, Inc. filed an 8-K on 2026-02-10 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 references financial statements and exhibits. No transaction details, financial metrics, positive or negative impacts, or other quantitative data are disclosed.

10-02-2026

IRADIMED CORP filed a Form 8-K on 2026-02-10 under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), disclosing financial results. No specific revenue, earnings, balance sheet impacts, guidance, period-over-period changes, or other quantitative metrics are provided in the filing summary. This is an informational earnings-related disclosure without detailed financial data.

10-02-2026

Aardvark Therapeutics, Inc. filed a Form 8-K on February 10, 2026, under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events or the contents of the exhibits are disclosed in the filing summary. No quantitative financial metrics, transactions, or performance comparisons (positive, negative, or flat) are mentioned.

10-02-2026

EQV Ventures Acquisition Corp. filed an 8-K on 2026-02-10 disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01 in connection with a merger/acquisition event. No specific deal structure, parties, valuation, financial metrics, or performance comparisons are explicitly stated in the provided filing information. Sector is not specified.

10-02-2026

Open Text Corp filed a Form 8-K on February 10, 2026, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are provided in the filing summary. This appears to be a multi-item informational filing with no disclosed quantitative impacts.

• ·Multi-item 8-K filing (Items 8.01 and 9.01)
• ·AccNo: 0001002638-26-000024

10-02-2026

Evommune, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001193125-26-043771), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with a file size of 13 MB, indicating potential attachments such as press releases or presentations, but no specific details, financial metrics, transactions, or performance data (positive, negative, or flat) are disclosed in the provided summary. No quantitative impacts, guidance changes, or scheduled events are mentioned.

10-02-2026

SCI Engineered Materials, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001104659-26-012363, Size: 168 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the exhibits are disclosed in the provided filing summary. No financial metrics, transactions, or directional impacts are mentioned.

10-02-2026

AtlasClear Holdings, Inc. filed a multi-item Form 8-K on February 10, 2026, disclosing entry into a material definitive agreement under Item 1.01, creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, unregistered sales of equity securities under Item 3.02, and other events under Item 8.01, with exhibits listed under Item 9.01. No quantitative details such as transaction values, share counts, financial impacts, or period-over-period comparisons are provided in the filing summary. No positive or negative metrics are disclosed.

10-02-2026

Middlefield Banc Corp filed a Form 8-K on February 10, 2026 (AccNo: 0001437749-26-003578), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific quantitative financial metrics, period-over-period comparisons, revenue, earnings, balance sheet changes, guidance, or other numerical data are disclosed in the provided filing information. This is an informational earnings-related disclosure with no directional performance indicators available.

10-02-2026

Mount Logan Capital Inc. filed an 8-K on February 10, 2026, disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names, reasons for change, or any quantitative impacts are NOT_DISCLOSED.

10-02-2026

RXO, Inc. filed an 8-K on February 10, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This multi-item filing represents a voluntary disclosure of potentially material non-public information with attached exhibits, but no specific details, metrics, positives, negatives, or flat performance indicators are provided in the summary. No quantitative financial or operational data is available.

10-02-2026

SAFE & GREEN HOLDINGS CORP. filed an 8-K on 2026-02-10 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, timing, or any quantitative metrics were disclosed.

10-02-2026

RGC Resources Inc filed an 8-K on February 10, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific core events, transactions, financial metrics, positive or negative changes, or quantitative data are disclosed in the provided filing information.

10-02-2026

Cencora, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001140859-26-000012, Size: 10 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. This appears to be a multi-item filing with potentially significant attachments given the file size.

10-02-2026

TruGolf Holdings, Inc. filed a Form 8-K on February 10, 2026, under Item 8.01 Other Events. No specific details of the event, transaction values, financial metrics, or impacts are disclosed in the provided filing information. This is a single-item filing with no quantitative data or named entities beyond the company itself.

10-02-2026

Hillenbrand, Inc. disclosed in its 8-K filing the entry into a new material definitive agreement (Item 1.01) and termination of a prior material definitive agreement (Item 1.02), alongside completion of an acquisition or disposition of assets (Item 2.01). The filing also reports creation of direct financial obligations (Item 2.03), notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to security holder rights (Item 3.03), changes in control of the registrant (Item 5.01), and changes in directors/officers including compensatory arrangements (Item 5.02), with partial mention of amendments to articles of incorporation (Item 5.03). No quantitative financial terms, parties involved, or specific impacts are disclosed.

10-02-2026

Prudential Financial Inc filed an 8-K on February 10, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names, reasons for change, appointment or resignation status, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

10-02-2026

Eva Live Inc filed an 8-K on February 10, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of any exhibits are disclosed in the filing summary. This is a multi-item filing with limited information provided.